Your browser doesn't support javascript.
loading
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Luen, S J; Salgado, R; Dieci, M V; Vingiani, A; Curigliano, G; Gould, R E; Castaneda, C; D'Alfonso, T; Sanchez, J; Cheng, E; Andreopoulou, E; Castillo, M; Adams, S; Demaria, S; Symmans, W F; Michiels, S; Loi, S.
Affiliation
  • Luen SJ; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • Salgado R; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
  • Dieci MV; University of Padova, Padova, Italy; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Vingiani A; European Institute of Oncology IRCCS, Milan, Italy.
  • Curigliano G; European Institute of Oncology IRCCS, Milan, Italy; University of Milano, Milan, Italy.
  • Gould RE; MD Anderson Cancer Centre, Houston, USA.
  • Castaneda C; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • D'Alfonso T; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Sanchez J; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Cheng E; Department of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA.
  • Andreopoulou E; Department of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA.
  • Castillo M; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Adams S; New York University School of Medicine, New York, USA.
  • Demaria S; Department of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA.
  • Symmans WF; MD Anderson Cancer Centre, Houston, USA.
  • Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, University Paris-Sud, University Paris-Saclay, Villejuif, France.
  • Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. Electronic address: sherene.loi@petermac.org.
Ann Oncol ; 30(2): 236-242, 2019 02 01.
Article in En | MEDLINE | ID: mdl-30590484
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphocytes, Tumor-Infiltrating / Neoplasm, Residual / Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphocytes, Tumor-Infiltrating / Neoplasm, Residual / Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Year: 2019 Type: Article